PT  - JOURNAL ARTICLE
AU  - Phillips, Aaron A.
AU  - Gandhi, Aasta P.
AU  - Hankov, Nicolas
AU  - Hernandez-Charpak, Sergio D.
AU  - Rimok, Julien
AU  - Incognito, Anthony
AU  - Nijland, Anouk E. J.
AU  - D’Ercole, Marina
AU  - Watrin, Anne
AU  - Berney, Maxime
AU  - Damianaki, Aikaterini
AU  - Dumont, Grégory
AU  - Macellari, Nicolò
AU  - De Herde, Laura
AU  - Baaklini, Edeny
AU  - Smith, Donovan
AU  - Miller, Ryan
AU  - Lee, Jordan
AU  - Intering, Nadine
AU  - Ledoux, Jean-Baptiste
AU  - Ordonnez, Javier G.
AU  - Newton, Taylor
AU  - Meliadò, Ettore F.
AU  - Duguet, Léa
AU  - Jacquet, Charlotte
AU  - Bole-Feysot, Léa
AU  - Rieger, Markus
AU  - Gelenitis, Kristen
AU  - Dumeny, Yoann
AU  - Caban, Miroslav
AU  - Ganty, Damien
AU  - Paoles, Edoardo
AU  - Baumgartner, Thomas
AU  - ,
AU  - ,
AU  - Harte, Cathal
AU  - Sasportes, Charles David
AU  - Romo, Paul
AU  - Vouga, Tristan
AU  - Fasola, Jemina
AU  - Ravier, Jimmy
AU  - Gautier, Matthieu
AU  - Merlos, Frédéric
AU  - Buschman, Rik
AU  - Milekovic, Tomislav
AU  - Rowald, Andreas
AU  - Mandija, Stefano
AU  - van den Berg, Cornelis A.T.
AU  - Kuster, Niels
AU  - Neufeld, Esra
AU  - Pralong, Etienne
AU  - Hirt, Lorenz
AU  - Carda, Stefano
AU  - Becce, Fabio
AU  - Aleton, Etienne
AU  - Rogan, Kyle
AU  - Schoettker, Patrick
AU  - Wuerzner, Grégoire
AU  - Langerak, Nelleke
AU  - Keijsers, Noël L.W.
AU  - Kwon, Brian K.
AU  - Guest, James D.
AU  - Ross, Erika
AU  - Murphy, John
AU  - Kurt, Erkan
AU  - Casha, Steve
AU  - Girgis, Fady
AU  - van Nes, Ilse
AU  - Larkin-Kaiser, Kelly A.
AU  - Demesmaeker, Robin
AU  - Asboth, Léonie
AU  - Squair, Jordan W.
AU  - Bloch, Jocelyne
AU  - Courtine, Grégoire
TI  - The implantable system that restores hemodynamic stability after spinal cord injury
AID  - 10.1101/2024.05.10.24306826
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.05.10.24306826
4099  - http://medrxiv.org/content/early/2024/05/15/2024.05.10.24306826.short
4100  - http://medrxiv.org/content/early/2024/05/15/2024.05.10.24306826.full
AB  - A spinal cord injury (SCI) causes immediate and sustained hemodynamic instability that threatens neurological recovery and impacts quality of life. Here, we establish the clinical burden of chronic hypotensive complications due to SCI and expose the ineffective treatment of these complications with conservative measures. To address this clinical burden, we developed a purpose-built implantable system based on biomimetic epidural electrical stimulation (EES) of the spinal cord that immediately triggered robust pressor responses. The system durably reduced the severity of hypotensive complications in people with SCI, removed the necessity for conservative treatments, improved quality of life, and enabled superior engagement in activities of daily living. Central to the development of this therapy was the head-to-head demonstration in the same participants that EES must target the last three thoracic segments, and not the lumbosacral segments, to achieve the safe and effective regulation of blood pressure in people with SCI. These findings establish a path forward to treat the underappreciated, treatment-resistant hypotensive complications due to SCI.Competing Interest StatementThe authors declare competing financial interests: G.C., A.Phillips., J.W.S, J.Bloch., R.D., L.Asboth, T.M. and A.R. hold various patents in relation with the present work. G.C., A.Philips., J.Bloch, V.D., J.Murphy and H.L. are minority shareholders of ONWARD medical, a company with direct relationships with the presented work. G.C., J.Bloch., A.Phillips. and R.D. are consultants of ONWARD medical. P.B., M.D., L.D., K.G., C.J., H.L., C.Picq, M.Rieger, E.R., R.V., A.W., F.A., S.Morand, J.Pradarelli, E.Paoles, J.Murphy, Y.D., M.C. D.G., A.K, J.D., F.S. and V.D. are employees of ONWARD medical. N.Kuster and E.N. are shareholders of ZMT Zurich MedTech AG, which produces the Sim4Life software. The other authors declare no competing interests.Clinical TrialNCT04994886 NCT05044923 NCT05111093 NCT05941819Funding StatementThis work was financially supported by: Eurostars project E!113969 PREP2GO, DARPA subaward A21-0795-S001 (P.O. 1083297), Eurostars E!1748 IMPULSE, Medtronic (ERP-2020-12543), Onward Medical, PHRT-279, the Defitech foundation, CIHR, Cumming Medical Research Fund, Edith Rodie Estate, Hotchkiss Brain Institute, Libin Cardiovascular Institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Swissethics gave ethical approval for this work (Ethics reference number: CER-VD 2021-00588). Swissmedic gave regulatory approval before the start of the study for the STIMO-HEMO trial conducted in Switzerland (Competent authorities number: Swissmedic 10000882). The STIMO-HEMO study followed the Declaration of Helsinki (clinicaltrials.gov ID: NCT 04994886). The Canadian ethical authorities gave ethical approval for this work (Ethics reference number: REB21-0027). The HEMO trial was conducted following the Declaration of Helsinki in Canada (clinicaltrials.gov ID: NCT 05044923). Swissethics gave ethical approval for this work (Ethics reference number: CER-VD 2021-D0025). Swissmedic gave regulatory approval before the start of the study for the HemON trial conducted in Switzerland (Competent authorities number: Swissmedic 10000932). The HemON study followed the Declaration of Helsinki (clinicaltrials.gov ID: NCT 05111093). The Central Committee on Research Involving Human Subjects of Radboud University Medical Center gave ethical approval for this work (Ethics reference number: 2023-16316). The Central Committee on Research Involving Human Subjects gave regulatory approval before the start of the study for the HemON-NL trial conducted in The Netherlands (CCMO NL83694.000.23). The HemON-NL study followed the Declaration of Helsinki (clinicaltrials.gov ID: NCT 05941819). Veritas Independent Review Board, the Research Ethics Board of Universite Laval (principal investigators institution) and local research ethics IRBs across Canada gave ethical approval for the epidemiological survey in this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSoftware routines developed for the data analysis will be made available upon reasonable request to the corresponding authors.